275 related articles for article (PubMed ID: 30855591)
1. [Sepsis biomarkers dynamics as an indicator of intensive care effectiveness].
Zvyagin AA; Demidova VS; Smirnov GV
Khirurgiia (Mosk); 2019; (2):53-57. PubMed ID: 30855591
[TBL] [Abstract][Full Text] [Related]
2. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.
Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z
Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590
[TBL] [Abstract][Full Text] [Related]
3. Serum Biomarkers for the Early Detection of the Early-Onset Neonatal Sepsis: A Single-Center Prospective Study.
Ahmed AM; Mohammed AT; Bastawy S; Attalla HA; Yousef AA; Abdelrazek MS; Fransawy Alkomos M; Ghareeb A
Adv Neonatal Care; 2019 Oct; 19(5):E26-E32. PubMed ID: 31651475
[TBL] [Abstract][Full Text] [Related]
4. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.
Pugni L; Pietrasanta C; Milani S; Vener C; Ronchi A; Falbo M; Arghittu M; Mosca F
PLoS One; 2015; 10(12):e0146020. PubMed ID: 26720209
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis.
Kumar N; Dayal R; Singh P; Pathak S; Pooniya V; Goyal A; Kamal R; Mohanty KK
Indian J Pediatr; 2019 Feb; 86(2):177-179. PubMed ID: 29577181
[TBL] [Abstract][Full Text] [Related]
6. Presepsin values as markers of severity of sepsis.
Aliu-Bejta A; Atelj A; Kurshumliu M; Dreshaj S; Baršić B
Int J Infect Dis; 2020 Jun; 95():1-7. PubMed ID: 32251795
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
[TBL] [Abstract][Full Text] [Related]
9. Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis.
Iskandar A; Arthamin MZ; Indriana K; Anshory M; Hur M; Di Somma S;
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3903-3908. PubMed ID: 29742943
[No Abstract] [Full Text] [Related]
10. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients.
Hassan EA; Abdel Rehim AS; Ahmed AO; Abdullahtif H; Attia A
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717340
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
[TBL] [Abstract][Full Text] [Related]
12. Presepsin: A potential superior diagnostic biomarker for the postmortem differentiation of sepsis based on the Sepsis-3 criteria.
Unuma K; Makino Y; Sasaki Y; Iwase H; Uemura K
Forensic Sci Int; 2019 Jun; 299():17-20. PubMed ID: 30954003
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis.
Ozdemir AA; Elgormus Y
Am J Perinatol; 2017 May; 34(6):550-556. PubMed ID: 27825177
[No Abstract] [Full Text] [Related]
14. Presepsin and Procalcitonin Levels as Markers of Adverse Postoperative Complications and Mortality in Cardiac Surgery Patients.
Clementi A; Virzì GM; Muciño-Bermejo MJ; Nalesso F; Giavarina D; Carta M; Brocca A; de Cal M; Hinna Danesi T; Zanella M; Marchionna N; Brendolan A; Battaglia GG; Salvador L; Ronco C
Blood Purif; 2019; 47(1-3):140-148. PubMed ID: 30336490
[TBL] [Abstract][Full Text] [Related]
15. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
[TBL] [Abstract][Full Text] [Related]
16. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.
Yoon SH; Kim EH; Kim HY; Ahn JG
BMC Infect Dis; 2019 Aug; 19(1):760. PubMed ID: 31470804
[TBL] [Abstract][Full Text] [Related]
17. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
[TBL] [Abstract][Full Text] [Related]
18. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients.
Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V
J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884
[TBL] [Abstract][Full Text] [Related]
19. Increased presepsin levels are associated with the severity of fungal bloodstream infections.
Bamba Y; Moro H; Aoki N; Koizumi T; Ohshima Y; Watanabe S; Sakagami T; Koya T; Takada T; Kikuchi T
PLoS One; 2018; 13(10):e0206089. PubMed ID: 30379880
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]